About WuXi PharmaTech (Cayman) (NYSE:WX)
WuXi PharmaTech (Cayman) Inc. is a pharmaceutical, biotechnology and medical device research and development (R&D) services company, with operations in China and the United States. The Company provides a portfolio of laboratory and manufacturing services throughout the drug and medical device R&D process to its customers. It conducts its operations in two segments: Laboratory services and Manufacturing services. The Company offers Laboratory services for pharmaceutical, biotechnology and medical device companies. It offers Manufacturing services, which include the development of manufacturing processes and the production of advanced intermediates and active pharmaceutical ingredients (APIs) for use by pharmaceutical companies in preclinical and clinical trials of small-molecule products and in commercial products, as well as the production of biologic products.
Industry, Sector and Symbol
Trailing P/E RatioN/A
Forward P/E RatioN/A
Sales & Book Value
Price / SalesN/A
Price / CashN/A
Price / BookN/A
EPS (Most Recent Fiscal Year)N/A
Return on Equity6.93%
Return on Assets4.67%
WuXi PharmaTech (Cayman) (NYSE:WX) Frequently Asked Questions
What is WuXi PharmaTech (Cayman)'s stock symbol?
WuXi PharmaTech (Cayman) trades on the New York Stock Exchange (NYSE) under the ticker symbol "WX."
How were WuXi PharmaTech (Cayman)'s earnings last quarter?
WuXi PharmaTech (Cayman) Inc. (NYSE:WX) released its quarterly earnings data on Tuesday, November, 3rd. The medical research company reported $0.31 earnings per share for the quarter, meeting the consensus estimate of $0.31. The medical research company earned $213.60 million during the quarter, compared to analysts' expectations of $205.24 million. WuXi PharmaTech (Cayman) had a net margin of 7.52% and a return on equity of 6.93%. The firm's quarterly revenue was up 23.0% on a year-over-year basis. During the same period in the previous year, the company earned $0.54 earnings per share. View WuXi PharmaTech (Cayman)'s Earnings History.
Who are some of WuXi PharmaTech (Cayman)'s key competitors?
Some companies that are related to WuXi PharmaTech (Cayman) include Old Republic International (ORI), TE Connectivity (TE), Guidewire Software (GWRE), KT (KT), VEREIT (VER), Henderson Group (JHG), EQT GP (EQGP), United Microelectronics (UMC), Antero Resources (AR), Toll Brothers (TOL), Oaktree Capital Management (OAK), Gildan Activewear (GIL), Gardner Denver (GDI), Plum Creek Timber (PCL), Enel Chile (ENIC), Carlisle Companies (CSL), Hanesbrands (HBI) and EPAM Systems (EPAM).
Has WuXi PharmaTech (Cayman) been receiving favorable news coverage?
Media headlines about WX stock have trended somewhat positive recently, Accern reports. Accern identifies positive and negative press coverage by analyzing more than 20 million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. WuXi PharmaTech (Cayman) earned a coverage optimism score of 0.07 on Accern's scale. They also gave news headlines about the medical research company an impact score of 45.59 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the stock's share price in the immediate future.
How do I buy shares of WuXi PharmaTech (Cayman)?
Shares of WX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is WuXi PharmaTech (Cayman)'s stock price today?
One share of WX stock can currently be purchased for approximately $45.91.
How big of a company is WuXi PharmaTech (Cayman)?
WuXi PharmaTech (Cayman) has a market capitalization of $3.27 billion.
How can I contact WuXi PharmaTech (Cayman)?
WuXi PharmaTech (Cayman)'s mailing address is 288 Fute Zhong Road China (Shanghai) Pilot Free Trade Zone, SHANGHAI, SHA 200131, China. The medical research company can be reached via phone at +86-21-50461111.
MarketBeat Community Rating for WuXi PharmaTech (Cayman) (WX)MarketBeat's community ratings are surveys of what our community members think about WuXi PharmaTech (Cayman) and other stocks. Vote "Outperform" if you believe WX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe WX will underperform the S&P 500 over the long term. You may vote once every thirty days.
WuXi PharmaTech (Cayman) (NYSE:WX) Analyst Ratings History
(Data available from 4/22/2016 forward)
|Date||Brokerage||Action||Rating||Price Target||Impact on Share Price||Details|
WuXi PharmaTech (Cayman) (NYSE:WX) Earnings History and Estimates Chart
WuXi PharmaTech (Cayman) (NYSE WX) Earnings History by Quarter
(Earnings results data provided by Zacks Investment Research)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|11/3/2015||Q3||$0.31||$0.31||$205.24 million||$213.60 million||View||N/A|
|8/13/2015||Q215||$0.39||$0.38||$195.26 million||$194.14 million||View||Listen|
|5/13/2015||Q1||$0.32||$0.36||$174.29 million||$180.00 million||View||Listen|
|3/5/2015||Q414||$0.53||$0.55||$189.54 million||$190.60 million||View||Listen|
|11/12/2014||Q314||$0.48||$0.54||$172.60 million||$173.60 million||View||Listen|
|8/13/2014||Q214||$0.47||$0.49||$162.11 million||$163.40 million||View||Listen|
|5/14/2014||Q114||$0.39||$0.30||$145.00 million||$146.70 million||View||Listen|
|3/5/2014||Q413||$0.43||$0.53||$155.76 million||$157.10 million||View||N/A|
|11/13/2013||Q313||$0.39||$0.47||$145.29 million||$146.70 million||View||Listen|
|8/12/2013||Q2 2013||$0.39||$0.46||$141.10 million||$142.33 million||View||N/A|
|5/13/2013||Q1 2013||$0.32||$0.35||$130.02 million||$131.90 million||View||Listen|
|3/7/2013||Q4 2012||$0.30||$0.38||$123.71 million||$125.70 million||View||Listen|
|11/12/2012||Q312||$0.30||$0.36||$123.17 million||$125.84 million||View||N/A|
WuXi PharmaTech (Cayman) (NYSE:WX) Dividend History by Quarter
(Data available from 1/1/2013 forward)
|Announced||Period||Amount||Yield||Ex-Dividend Date||Record Date||Payable Date|
WuXi PharmaTech (Cayman) (NYSE WX) Insider Trading and Institutional Ownership History
WuXi PharmaTech (Cayman) (NYSE WX) Insider Trading History
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Shares Held After Transaction||Details|
WuXi PharmaTech (Cayman) (NYSE WX) News Headlines
WuXi PharmaTech (Cayman) (NYSE:WX) SEC Filings
This page is loading this company's SEC Filings. Please wait...
WuXi PharmaTech (Cayman) (NYSE:WX) Income Statement, Balance Sheet and Cash Flow Statement
WuXi PharmaTech (Cayman) (NYSE WX) Stock Chart for Sunday, April, 22, 2018